DNPM
German Network for Personalised Medicine
The aim of the project is to set up centers for personalized medicine throughout Germany and to pool expertise in a German Network for Personalized Medicine (DNPM). In particular, the project partners will develop joint standards and establish so-called „molecular tumor boards“ in order to provide patients with the best possible individual treatment at the end of guideline-based therapy. A joint database will be used for quality assurance and provide new findings for the further development of personalized medicine. The accompanying evaluation will examine in particular whether patients benefit directly from the new standards and structures and what challenges are associated with the establishment of such centers. The Certification Commission of the German Cancer Society for Centers for Personalized Medicine has developed requirements on the basis of which 12 centers have already been certified (as of 2/2024; www.oncomap.de).
Involved Institutions
Among others
Charité-Universitätsmedizin Berlin
Heinrich-Heine-Universität Düsseldorf
Klinikum der Universität München
Klinikum rechts der Isar
Technische Universität Dresden
Universität Ulm
Universitätsklinikum Aachen
Universitätsklinikum Bonn
Universitätsklinikum Essen
Universitätsklinikum Frankfurt
Universitätsklinikum Freiburg
Universitätsklinikum Hamburg-Eppendorf
Universitätsklinikum Heidelberg
Universitätsklinikum Köln
Universitätsklinikum Würzburg
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Universitätsklinikum Gießen und Marburg GmbH
Universitätsklinikum Münster
Medizinische Hochschule Hannover
Universitätsklinikum Göttingen
German Cancer Society (DKG)
Funding
Innovation Committee of The Federal Joint Committee (G-BA)
Duration
August 2021 – December 2024
Publications
see publications
Website
https://dnpm.de/
